Synthesis of 1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one and related compounds as acetylcholine release enhancers

Mei Shan Lin, Ling Wei Hsin, Hui Bing Tsai, Ming Cheng Tsai, Chen Yu Cheng

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Acetylcholine release enhancers may have therapeutic value in the treatment of Alzheimer's disease. A series of 1,4-dihydro-4,4-bis(pyridinylmethyl)-2H-isoquinolin-3-ones (2-13) was synthesized as analogs of the known acetylcholine-release enhancer linopirdine (1). Their cholinergic activity was measured as the enhancement of indirectly-elicited twitch tension of the mouse diaphragm. Among the target compounds, 2-phenyl-4,4-bis(4-pyridinylmethyl)-4H-isoquinoline-1,3-dione (2) and 7-bromo-1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one (11) were found to be more potent than 1.

Original languageEnglish
Pages (from-to)271-281
Number of pages11
JournalChinese Pharmaceutical Journal
Volume54
Issue number4
Publication statusPublished - Aug 2002

Fingerprint

linopirdine
Acetylcholine
Diaphragm
Cholinergic Agents
Alzheimer Disease
Therapeutics
isoquinoline

Keywords

  • Acetylcholine release enhancers
  • Alzheimer's disease
  • Linopirdine

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Synthesis of 1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one and related compounds as acetylcholine release enhancers. / Lin, Mei Shan; Hsin, Ling Wei; Tsai, Hui Bing; Tsai, Ming Cheng; Cheng, Chen Yu.

In: Chinese Pharmaceutical Journal, Vol. 54, No. 4, 08.2002, p. 271-281.

Research output: Contribution to journalArticle

@article{9e7de0d2042545bebf684a028c0c448c,
title = "Synthesis of 1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one and related compounds as acetylcholine release enhancers",
abstract = "Acetylcholine release enhancers may have therapeutic value in the treatment of Alzheimer's disease. A series of 1,4-dihydro-4,4-bis(pyridinylmethyl)-2H-isoquinolin-3-ones (2-13) was synthesized as analogs of the known acetylcholine-release enhancer linopirdine (1). Their cholinergic activity was measured as the enhancement of indirectly-elicited twitch tension of the mouse diaphragm. Among the target compounds, 2-phenyl-4,4-bis(4-pyridinylmethyl)-4H-isoquinoline-1,3-dione (2) and 7-bromo-1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one (11) were found to be more potent than 1.",
keywords = "Acetylcholine release enhancers, Alzheimer's disease, Linopirdine, Acetylcholine release enhancers, Alzheimer's disease, Linopirdine",
author = "Lin, {Mei Shan} and Hsin, {Ling Wei} and Tsai, {Hui Bing} and Tsai, {Ming Cheng} and Cheng, {Chen Yu}",
year = "2002",
month = "8",
language = "English",
volume = "54",
pages = "271--281",
journal = "Taiwan Pharmaceutical Journal",
issn = "1016-1015",
publisher = "臺灣藥學會",
number = "4",

}

TY - JOUR

T1 - Synthesis of 1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one and related compounds as acetylcholine release enhancers

AU - Lin, Mei Shan

AU - Hsin, Ling Wei

AU - Tsai, Hui Bing

AU - Tsai, Ming Cheng

AU - Cheng, Chen Yu

PY - 2002/8

Y1 - 2002/8

N2 - Acetylcholine release enhancers may have therapeutic value in the treatment of Alzheimer's disease. A series of 1,4-dihydro-4,4-bis(pyridinylmethyl)-2H-isoquinolin-3-ones (2-13) was synthesized as analogs of the known acetylcholine-release enhancer linopirdine (1). Their cholinergic activity was measured as the enhancement of indirectly-elicited twitch tension of the mouse diaphragm. Among the target compounds, 2-phenyl-4,4-bis(4-pyridinylmethyl)-4H-isoquinoline-1,3-dione (2) and 7-bromo-1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one (11) were found to be more potent than 1.

AB - Acetylcholine release enhancers may have therapeutic value in the treatment of Alzheimer's disease. A series of 1,4-dihydro-4,4-bis(pyridinylmethyl)-2H-isoquinolin-3-ones (2-13) was synthesized as analogs of the known acetylcholine-release enhancer linopirdine (1). Their cholinergic activity was measured as the enhancement of indirectly-elicited twitch tension of the mouse diaphragm. Among the target compounds, 2-phenyl-4,4-bis(4-pyridinylmethyl)-4H-isoquinoline-1,3-dione (2) and 7-bromo-1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one (11) were found to be more potent than 1.

KW - Acetylcholine release enhancers

KW - Alzheimer's disease

KW - Linopirdine

KW - Acetylcholine release enhancers

KW - Alzheimer's disease

KW - Linopirdine

UR - http://www.scopus.com/inward/record.url?scp=0036703912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036703912&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 271

EP - 281

JO - Taiwan Pharmaceutical Journal

JF - Taiwan Pharmaceutical Journal

SN - 1016-1015

IS - 4

ER -